Vitamin Shoppe Inc. (NYSE:VSI) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Thursday.
According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “
A number of other analysts have also issued reports on the company. Jefferies Group restated a “hold” rating and issued a $28.00 target price on shares of Vitamin Shoppe in a report on Monday, September 26th. Barclays PLC assumed coverage on Vitamin Shoppe in a report on Thursday, September 22nd. They issued an “equal weight” rating and a $29.00 target price for the company. Finally, Wedbush restated an “outperform” rating and issued a $39.00 target price on shares of Vitamin Shoppe in a report on Wednesday, August 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $32.27.
Shares of Vitamin Shoppe (NYSE:VSI) opened at 27.48 on Thursday. The stock has a 50 day moving average price of $27.04 and a 200 day moving average price of $29.07. Vitamin Shoppe has a 12 month low of $26.02 and a 12 month high of $34.41. The stock has a market cap of $648.09 million, a P/E ratio of 16.10 and a beta of 0.55.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.59 by $0.04. The business earned $332.70 million during the quarter, compared to analysts’ expectations of $331.58 million. Vitamin Shoppe had a net margin of 3.56% and a return on equity of 11.53%. Vitamin Shoppe’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.57 EPS. Equities analysts anticipate that Vitamin Shoppe will post $2.18 EPS for the current fiscal year.
Large investors have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of Vitamin Shoppe during the fourth quarter valued at about $7,955,000. BlackRock Group LTD increased its stake in Vitamin Shoppe by 7.3% in the first quarter. BlackRock Group LTD now owns 37,164 shares of the company’s stock worth $1,150,000 after buying an additional 2,521 shares during the period. Menta Capital LLC increased its stake in Vitamin Shoppe by 102.9% in the first quarter. Menta Capital LLC now owns 14,200 shares of the company’s stock worth $440,000 after buying an additional 7,200 shares during the period. UBS Group AG increased its stake in Vitamin Shoppe by 390.6% in the first quarter. UBS Group AG now owns 91,027 shares of the company’s stock worth $2,819,000 after buying an additional 72,471 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Vitamin Shoppe by 152.4% in the first quarter. Goldman Sachs Group Inc. now owns 104,812 shares of the company’s stock worth $3,245,000 after buying an additional 63,278 shares during the period.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related companies with MarketBeat.com's FREE daily email newsletter.